Nemesis Bioscience
PrivateCompany Overview
Nemesis Bioscience operates in Healthcare & Life Sciences and is based in Cambridge. It was founded in 2014.
Nemesis Bioscience was a biopharmaceutical company that developed DNA therapeutics designed to reverse microbial resistance to antibiotics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nemesis Bioscience Comparables
Compare Nemesis Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eligo Bioscience | 82% | |
| Procarta Biosystems | 78% | |
| Locus Biosciences | 76% |
For institutional investors. Book with your work email.
Nemesis Bioscience Funding Rounds
Historical fundraising activity
Nemesis Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nemesis Bioscience's valuation, stock price, and market status.
Is Nemesis Bioscience a public or private company?
Nemesis Bioscience is a private company.
What is the current stock price of Nemesis Bioscience?
Nemesis Bioscience is a private company, so its shares have no public market price. Caplight tracks Nemesis Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nemesis Bioscience worth (valuation)?
Valuation information for Nemesis Bioscience is not publicly available.
Can I buy Nemesis Bioscience stock?
Nemesis Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nemesis Bioscience's last funding round?
Funding round information for Nemesis Bioscience is not publicly available.
Who are the main investors in Nemesis Bioscience?
Investor information for Nemesis Bioscience is not publicly disclosed.
Will Nemesis Bioscience IPO soon?
No public IPO plans have been announced for Nemesis Bioscience.
How can I track Nemesis Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Nemesis Bioscience's shares on secondary markets.